triflupromazine has been researched along with Atherosclerotic Parkinsonism in 1 studies
Triflupromazine: A phenothiazine used as an antipsychotic agent and as an antiemetic.
triflupromazine : A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(dimethylamino)propyl group at the N-10 position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maickel, RP | 1 |
| Braunstein, MC | 1 |
| McGlynn, M | 1 |
| Snodgrass, WR | 1 |
| Webb, RW | 1 |
1 other study available for triflupromazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Behavioral, biochemical, and pharmacological effects of chronic dosage of phenothiazine tranquilizers in rats.
Topics: Animals; Avoidance Learning; Behavior, Animal; Body Weight; Brain Chemistry; Chlorpromazine; Dose-Re | 1974 |